Skip to main content

Table 1 Analysed mutations in PSEN2, their location and associated AAOs

From: Spectrum of γ-Secretase dysfunction as a unifying predictor of ADAD age at onset across PSEN1, PSEN2 and APP causal genes

 

PSEN2 mutation

Position in PSEN2

Mean AAO (range)

# Cases

Classification

1

A85V

N-term

61.5 (55.0–71.0)

4

Not classified

2

T122P

Loop 1

47.3 (46.0–50.0)

3

Likely pathogenic

3

P123L

Loop 1

57.0

1

Not classified

4

E126K

Loop 1

53.5 (48.0–59.0)

2

Not classified

5

S130L

Loop 1

65.2 (51.0–81.0)

9

Uncertain significance

6

N141D

TMD 2

59.0

1

Not classified

7

N141I

TMD 2

56.6 (40.0–76.0)

87/101 (*)

Pathogenic

8

N141S

TMD 2

52.0

1

Not classified

9

N141Y

TMD 2

46.0 (43.0–49.0)

2

Likely pathogenic

10

I149T

TMD 2

63.0

1

Not classified

11

K161R

Loop 2

65.0

1

Not classified

12

H169N

Loop 2

62.5 (56.0–68.0)

4

Uncertain significance

13

S175C

TMD 3

62.0 (60.0–65.0)

3

Not classified

14

S175F

TMD 3

53.0 (49.0–58.0)

3

Not classified

15

G212V

TMD 4

61.5 (60.0–65.0)

4

Not classified

16

I235F

TMD5

57.0

1

Not classified

17

L238F

TMD 5

60.0 (49.0–74.0)

4

Uncertain significance

18

M239I

TMD 5

50.1 (30.0–58.0)

16/20 (*)

Pathogenic

19

M239V

TMD 5

57.2 (45.0–83.0)

28/44 (*)

Pathogenic

20

M239T

TMD 5

52.0 (47.0–59.0)

3

Pathogenic

21

R284G

Loop 6

57.5 (57.0–58.0)

2

Likely pathogenic

22

M298T

Loop 6

57.2 (56.0–59.0)

5

Likely pathogenic

23

A379D

Loop 7

55.0

1

Not classified

24

P69A

N-term

74.0

1

Benign

25

R71W

N-term

63.4 (55.0–75.0)

9/18 (*)

Benign

26

V214L

TMD 4

57.2 (42.0–69.0)

11/13 (*)

Benign

27

P334A

Loop 6

Not reported

1

Benign

28

T421M

TMD 9

55.0

1

Benign

  1. This table summarizes analysed PSEN2 mutations, including their positions in the PSEN2 primary structure, associated AAOs, number of cases, and classification. AAOs were obtained from the Alzforum database and literature (see Supplementary Table S1). Mutations reported as pathogenic/likely pathogenic are highlighted in bold. P69A, R71W, V214L, P334A, and T421M substitutions, reported as benign, were selected as controls. Abbreviations: Transmembrane domain (TMD), extracellular loop between TMD1 and TMD2 in PSEN (Loop 1), N-terminal region (N-term). (*) Number of carriers included in this study vs total reported cases according to the Alzforum database